HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells.

Abstract
Natural killer (NK) cells are highly specialized effectors of the innate immune system that hold promise for adoptive cancer immunotherapy. Their cell killing activity is primarily mediated by the pro-apoptotic serine protease granzyme B (GrB), which enters targets cells with the help of the pore-forming protein perforin. We investigated expression of a chimeric GrB fusion protein in NK cells as a means to augment their antitumoral activity. For selective targeting to tumor cells, we fused the epidermal growth factor receptor (EGFR) peptide ligand transforming growth factor α (TGFα) to human pre-pro-GrB. Established human NKL natural killer cells transduced with a lentiviral vector expressed this GrB-TGFα (GrB-T) molecule in amounts comparable to endogenous wildtype GrB. Activation of the genetically modified NK cells by cognate target cells resulted in the release of GrB-T together with endogenous granzymes and perforin, which augmented the effector cells' natural cytotoxicity against NK-sensitive tumor cells. Likewise, GrB-T was released into the extracellular space upon induction of degranulation with PMA and ionomycin. Secreted GrB-T fusion protein displayed specific binding to EGFR-overexpressing tumor cells, enzymatic activity, and selective target cell killing in the presence of an endosomolytic activity. Our data demonstrate that ectopic expression of a targeted GrB fusion protein in NK cells is feasible and can enhance antitumoral activity of the effector cells.
AuthorsPranav Oberoi, Robert A Jabulowsky, Hayat Bähr-Mahmud, Winfried S Wels
JournalPloS one (PLoS One) Vol. 8 Issue 4 Pg. e61267 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID23573299 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Recombinant Fusion Proteins
  • Transforming Growth Factor alpha
  • ErbB Receptors
  • Granzymes
Topics
  • Apoptosis
  • Cell Degranulation
  • Cell Survival
  • Cytotoxicity, Immunologic
  • Drug Delivery Systems
  • ErbB Receptors (metabolism)
  • Gene Expression
  • Granzymes (biosynthesis, genetics, metabolism)
  • HEK293 Cells
  • Humans
  • Immunotherapy
  • Jurkat Cells
  • Killer Cells, Natural (immunology, metabolism)
  • Recombinant Fusion Proteins (biosynthesis, genetics, metabolism)
  • Transforming Growth Factor alpha (biosynthesis, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: